182 related articles for article (PubMed ID: 22149274)
1. Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A.
Corbett CR; Ballegeer E; Weedmark KA; Elias MD; Al-Saleem FH; Ancharski DM; Simpson LL; Berry JD
Hybridoma (Larchmt); 2011 Dec; 30(6):503-10. PubMed ID: 22149274
[TBL] [Abstract][Full Text] [Related]
2. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.
Amersdorfer P; Wong C; Chen S; Smith T; Deshpande S; Sheridan R; Finnern R; Marks JD
Infect Immun; 1997 Sep; 65(9):3743-52. PubMed ID: 9284147
[TBL] [Abstract][Full Text] [Related]
5. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
[TBL] [Abstract][Full Text] [Related]
7. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
[TBL] [Abstract][Full Text] [Related]
9. Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.
Atassi MZ; Dolimbek BZ
Protein J; 2004 Jan; 23(1):39-52. PubMed ID: 15115181
[TBL] [Abstract][Full Text] [Related]
10. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
[TBL] [Abstract][Full Text] [Related]
11. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A.
Brier S; Rasetti-Escargueil C; Wijkhuisen A; Simon S; Marechal M; Lemichez E; Popoff MR
FASEB J; 2021 May; 35(5):e21540. PubMed ID: 33817838
[TBL] [Abstract][Full Text] [Related]
13. Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.
Meng Q; Garcia-Rodriguez C; Manzanarez G; Silberg MA; Conrad F; Bettencourt J; Pan X; Breece T; To R; Li M; Lee D; Thorner L; Tomic MT; Marks JD
Anal Biochem; 2012 Nov; 430(2):141-50. PubMed ID: 22922799
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of a neutralizing antibody against botulinum neurotoxin A.
Xiong X; Lv S; Fu C; Li L; Sun Z; Han X; Zhang W
J Immunol Methods; 2020 Dec; 487():112871. PubMed ID: 33007319
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
[TBL] [Abstract][Full Text] [Related]
16. Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.
Avril A; Miethe S; Popoff MR; Mazuet C; Chahboun S; Rasetti-Escargueil C; Sesardic D; Thullier P; Hust M; Pelat T
BMC Biotechnol; 2015 Sep; 15():86. PubMed ID: 26382731
[TBL] [Abstract][Full Text] [Related]
17. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.
Kalb SR; Lou J; Garcia-Rodriguez C; Geren IN; Smith TJ; Moura H; Marks JD; Smith LA; Pirkle JL; Barr JR
PLoS One; 2009; 4(4):e5355. PubMed ID: 19399171
[TBL] [Abstract][Full Text] [Related]
18. Development of highly sensitive chemiluminescence enzyme immunoassay based on the anti-recombinant H(C) subunit of botulinum neurotoxin type A monoclonal antibodies.
Liu Z; Song C; Li Y; Liu F; Zhang K; Sun Y; Li H; Wei Y; Xu Z; Zhang C; Yang A; Xu Z; Yang K; Jin B
Anal Chim Acta; 2012 Jul; 735():23-30. PubMed ID: 22713913
[TBL] [Abstract][Full Text] [Related]
19. Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins.
Adekar SP; Jones RM; Elias MD; Al-Saleem FH; Root MJ; Simpson LL; Dessain SK
J Immunol Methods; 2008 Apr; 333(1-2):156-66. PubMed ID: 18313069
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of the Hcc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli and its immunogenicity as an antigen.
Yu YZ; Sun ZW; Wang S; Yu WY
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):812-7. PubMed ID: 18051857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
